More than 2 billion people have been exposed to the hepatitis B virus (HBV) of whom an
estimated 257 million people have chronic infection. 1 Chronic HBV infection occurs globally …

Our understanding of the natural history of hepatitis B virus (HBV) infection and the potential
for therapy of the resultant disease is continuously improving. New data have become …

Hepatitis B virus (HBV) infection is an important public health problem in Canada. In keeping
with evolving evidence and understanding of HBV pathogenesis, the Canadian Association …

Worldwide, some 240 million people have chronic hepatitis B virus (HBV), with the highest
rates of infection in Africa and Asia. Our understanding of the natural history of HBV infection …

Chronic hepatitis B virus (HBV) infection affects about 296 million people worldwide and is
the leading aetiology of cirrhosis and liver cancer globally. Major medical complications also …

More than 250 million people worldwide are chronically infected with the hepatitis B virus
(HBV). In this Comment, members of the International Coalition to Eliminate HBV appraise …

This AASLD 2018 Hepatitis B Guidance is intended to complement the AASLD 2016
Practice Guidelines for Treatment of Chronic Hepatitis B (1) and update the previous …

Background & Aims The American Association for the Study of Liver Diseases (AASLD)
guidelines for treatment of chronic hepatitis B virus (HBV) infection have changed with time …

The hepatitis B virus (HBV) remains a major contributor to the global burden of disease, with
more than 2 billion people exposed, of whom an estimated 257 million have chronic …

In 2013, viral hepatitis was a leading cause of death worldwide (1.46 million deaths, a toll
higher than that from HIV, tuberculosis or malaria, and on the increase since 1990)(1). More …